Consultation Launched on Proposed Changes to the ABPI Code of Practice for the Pharmaceutical Industry?
Consultation launched on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry and the Constitution and Procedure for the Prescription Medicines Code of Practice Authority
Changes are proposed to the 2014 ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure.
There are a number of reasons for the changes including the work done by the group established by the ABPI Board to review the Code. Additional changes are also needed to implement fully the European Federation of Pharmaceutical Industry Associations (EFPIA) Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations.
Updates to the EFPIA Disclosure Code and the EFPIA Code on the Promotion of Prescription-Only Medicines to, and Interactions with, Healthcare Professionals were agreed at the EFPIA General Assembly on 6 June 2014. The Medicines and Healthcare Products Regulatory Agency (MHRA) consultation as part of the red tape challenge and the regular update of the Code and its operation have also resulted in proposals.
Key proposals relate to changes around transparency and disclosure of some payments to health professionals including the creation of a central platform for disclosure, updates to certification requirements for Joint Working and the proposed introduction of a Product Related Service Provison.
The attached documents set out proposals to amend the ABPI Code and the Constitution and Procedure.
1. Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry
2. Proposals to amend the PMCPA Constitution and Procedure
6. Draft template (UK amendments to EFPIA version).
The timetable is as follows:
Friday, 11 July
Proposals sent to ABPI members, non members that have agreed to comply with the Code and those organisations cited in the PMCPA Constitution and Procedure. Proposals put on the PMCPA website for public consultation.
Friday, 5 September
Consultation closes.
Tuesday, 7 October
Final proposals to be agreed by the ABPI Board of Management.
Thursday, 20 November
Proposals to be before the ABPI Half-Yearly General Meeting.
Thursday, 1 January 2015
New Code to come into operation.
Related News
-
News PSCI Welcomes Delpharm, Samsung Biologics, and Suven as First Supplier Partners
The pharmaceutical industry continues to evolve with an increasing focus on responsible sourcing, sustainability, and collaboration across the supply chain. Under a new model to recognise suppliers within the pharmaceutical and healthcare industry that... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Eli Lilly's weight loss drugs removed from the FDA's shortage list
The US FDA have recently updated their drug shortage list. The recently released list shows that all dosage forms of Eli Lilly's weight-loss drug Zepbound and their diabetes drug Mounjaro are now available. -
News Global advancements in the diagnosis and treatment of rare diseases: Rare Disease Day 2024
Rare Diseases Day is celebrated on the 29th February 2024 and represents the plight of rare disease patients to gain diagnosis and access to suitable treatment. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance